Gaël Mouterde

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

Rakiba Belkhir, S. Le Burel, Laetitia Dunogeant et al. · Annals of the Rheumatic Diseases · 2017 · 242 citations

Life Sciences, Immunology, Pharmacotherapy +17

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

Maxime Dougados, Martin Soubrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2014 · 160 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints—an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force

Georgios Filippou, Carlo Alberto Scirè, Antonella Adinolfi et al. · Annals of the Rheumatic Diseases · 2018 · 94 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with rheumatoid arthritis

Bruno Fautrel, Thao Pham, Gaël Mouterde et al. · Joint Bone Spine · 2007 · 64 citations

Medicine, Immunology, Pharmacotherapy +15

JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis

Louise Gillard, J. Pouchot, Fleur Cohen‐Aubart et al. · Lara D. Veeken · 2022 · 60 citations

Medicine, Internal Medicine, Pharmacotherapy +16